Immunovant, Inc. (IMVT)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS45258J1025
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Immunovant, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:45. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 05 Feb 2027 08:00 | -0.58 | — | — | Upcoming |
| 09 Nov 2026 07:00 | -0.72 | -0.41 | +43.7% | Beat |
| 06 Aug 2026 07:00 | -0.61 | -0.68 | -10.5% | Miss |
| 20 May 2026 07:00 | -0.63 | -0.67 | -7.5% | Miss |
| 06 Feb 2026 07:00 | -0.69 | -0.54 | +22.4% | Beat |
| 10 Nov 2025 07:00 | -0.73 | -0.65 | +10.6% | Beat |
| 11 Aug 2025 07:00 | -0.67 | -0.71 | -5.4% | Miss |
| 29 May 2025 07:00 | -0.72 | -0.64 | +10.7% | Beat |
| 06 Feb 2025 06:00 | -0.75 | -0.76 | -1.0% | Miss |
| 07 Nov 2024 06:00 | -0.59 | -0.74 | -24.5% | Miss |
| 06 Aug 2024 16:00 | -0.52 | -0.60 | -16.2% | Miss |
| 29 May 2024 16:00 | -0.43 | -0.52 | -22.2% | Miss |
| 12 Feb 2024 07:00 | -0.42 | -0.36 | +14.4% | Beat |
| 09 Nov 2023 07:00 | -0.46 | -0.45 | +1.3% | Beat |
| 10 Aug 2023 07:00 | -0.44 | -0.57 | -30.5% | Miss |
| 22 May 2023 07:00 | -0.41 | -0.46 | -11.2% | Miss |
| 03 Feb 2023 07:00 | -0.37 | -0.49 | -31.0% | Miss |
| 04 Nov 2022 07:00 | -0.36 | -0.41 | -14.3% | Miss |
| 05 Aug 2022 07:00 | -0.40 | -0.35 | +12.5% | Beat |
| 08 Jun 2022 07:00 | -0.35 | -0.41 | -15.8% | Miss |
| 04 Feb 2022 07:00 | -0.31 | -0.36 | -15.4% | Miss |
| 05 Nov 2021 07:00 | -0.27 | -0.35 | -29.6% | Miss |
| 09 Aug 2021 06:00 | -0.32 | -0.31 | +2.1% | Beat |
| 01 Jun 2021 07:00 | -0.34 | -0.29 | +14.2% | Beat |
| 16 Feb 2021 08:00 | -0.25 | -0.32 | -25.6% | Miss |
| 12 Nov 2020 08:00 | -0.30 | -0.25 | +17.8% | Beat |
| 12 Aug 2020 16:00 | -0.32 | -0.38 | -18.0% | Miss |
| 29 Jun 2020 07:00 | -0.28 | -0.38 | -35.7% | Miss |
| 14 Feb 2020 07:00 | -0.25 | -0.28 | -9.8% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 0 | — | -505.6M | — | -2.77 | -1.5% | -407.3M |
| 2025 | 0 | — | -413.8M | — | -2.73 | -45.2% | -376.6M |
| 2024 | 0 | — | -259.3M | — | -1.88 | -9.9% | -214.6M |
| 2023 | 0 | — | -211M | — | -1.71 | — | -188.4M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 36.92 | 36.92 | 34.86 | 35.05 | -5.37% | 1,182,900 | |
| 11 Nov 2026 | 35.77 | 37.59 | 35.52 | 37.04 | +3.72% | 1,712,200 | |
| 10 Nov 2026 | 35.15 | 35.98 | 34.83 | 35.71 | +1.59% | 1,644,300 | |
| 09 Nov 2026 | 33.32 | 35.61 | 32.81 | 35.15 | +15.13% | 3,978,200 | |
| 06 Nov 2026 | 28.73 | 30.61 | 28.34 | 30.53 | +7.54% | 2,658,300 | |
| 05 Nov 2026 | 29.78 | 29.83 | 28.12 | 28.39 | -5.05% | 1,120,800 | |
| 04 Nov 2026 | 29.82 | 29.93 | 28.50 | 29.90 | +2.96% | 1,270,500 | |
| 03 Nov 2026 | 28.70 | 29.48 | 28.42 | 29.04 | +2.22% | 1,079,700 | |
| 02 Nov 2026 | 29.32 | 29.64 | 28.38 | 28.41 | -2.61% | 1,268,000 | |
| 30 Oct 2026 | 29.49 | 29.78 | 28.75 | 29.17 | -1.59% | 1,165,400 | |
| 1,249 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Does Immunovant (IMVT) Have the Potential to Rally 30.52% as Wall Street Analysts Expect? (opens in a new tab) Zacks · 11 Nov 2026 20:19
- Immunovant (IMVT) Upgraded to Buy: Here's What You Should Know (opens in a new tab) Zacks · 11 Nov 2026 16:00
- Truist Securities Maintains Hold on Immunovant, Raises Price Target to $33 (opens in a new tab) Benzinga · 10 Nov 2026 11:51
- Wells Fargo Maintains Overweight on Immunovant, Raises Price Target to $47 (opens in a new tab) Benzinga · 10 Nov 2026 10:59
- Immunovant (IMVT) Q2 2027 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 02:03
- Immunovant, Inc. Q2 2027 Earnings Call Summary (opens in a new tab) Moby · 10 Nov 2026 01:55
- Immunovant Stock What Changed After Arthritis Trial Success (opens in a new tab) Simply Wall St. · 09 Nov 2026 23:23
- Immunovant, Inc. (IMVT) Q2 2027 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 09 Nov 2026 17:01
- What Immunovant (IMVT) Said on Its Q2 Earnings Call (opens in a new tab) MarketBeat · 09 Nov 2026 16:15
- Immunovant surges on trial results, earnings beat (opens in a new tab) Investing.com · 09 Nov 2026 14:58
- Immunovant Meets Primary Endpoint In Difficult-To-Treat Rheumatoid Arthritis Study (opens in a new tab) Benzinga · 09 Nov 2026 13:23
- Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026 (opens in a new tab) 09 Nov 2026 12:00
- Immunovant Files Prospectus For Offering Mixed Shelf; Terms Undisclosed (opens in a new tab) Benzinga · 09 Nov 2026 08:50
- Immunovant (IMVT) Stock Looks Stretched On Book Value Alone (opens in a new tab) Simply Wall St. · 20 Oct 2026 15:14
- IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class (opens in a new tab) Stocktwits · 08 Oct 2026 18:33
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 37.04 USD
- Market cap
- 7.3B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow IMVT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.